178 related articles for article (PubMed ID: 23763435)
1. Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.
Bestard O; Crespo E; Stein M; Lúcia M; Roelen DL; de Vaal YJ; Hernandez-Fuentes MP; Chatenoud L; Wood KJ; Claas FH; Cruzado JM; Grinyó JM; Volk HD; Reinke P
Am J Transplant; 2013 Jul; 13(7):1880-90. PubMed ID: 23763435
[TBL] [Abstract][Full Text] [Related]
2. Porcine antigen-specific IFN-γ ELISpot as a potentially valuable tool for monitoring cellular immune responses in pig-to-non-human primate islet xenotransplantation.
Kim HJ; Yoon IH; Min BH; Kim YH; Shin JS; Kim JM; Kim JS; Nam HY; Lee WW; Park CG
Xenotransplantation; 2016 Jul; 23(4):310-9. PubMed ID: 27464486
[TBL] [Abstract][Full Text] [Related]
3. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
[TBL] [Abstract][Full Text] [Related]
4. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
6. Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.
Bestard O; Cruzado JM; Lucia M; Crespo E; Casis L; Sawitzki B; Vogt K; Cantarell C; Torras J; Melilli E; Mast R; Martinez-Castelao A; Gomà M; Reinke P; Volk HD; Grinyó JM
Kidney Int; 2013 Dec; 84(6):1226-36. PubMed ID: 23783240
[TBL] [Abstract][Full Text] [Related]
7. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients.
Bestard O; Nickel P; Cruzado JM; Schoenemann C; Boenisch O; Sefrin A; Grinyó JM; Volk HD; Reinke P
J Am Soc Nephrol; 2008 Jul; 19(7):1419-29. PubMed ID: 18417724
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.
Nickel P; Presber F; Bold G; Biti D; Schönemann C; Tullius SG; Volk HD; Reinke P
Transplantation; 2004 Dec; 78(11):1640-6. PubMed ID: 15591953
[TBL] [Abstract][Full Text] [Related]
9. Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium.
Waerlop G; Leroux-Roels G; Lambe T; Bellamy D; Medaglini D; Pettini E; Cox RJ; Trieu MC; Davies R; Bredholt G; Montomoli E; Gianchecchi E; Clement F
Front Immunol; 2022; 13():984642. PubMed ID: 36159843
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
[TBL] [Abstract][Full Text] [Related]
12. Donor non-specific IFN-gamma production by primed alloreactive cells as a potential screening test to predict the alloimmune response.
Bendjelloul F; Desin TS; Shoker AS
Transpl Immunol; 2004 Jan; 12(2):167-76. PubMed ID: 14967315
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
[TBL] [Abstract][Full Text] [Related]
14. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.
Augustine JJ; Poggio ED; Heeger PS; Hricik DE
Transplantation; 2008 Aug; 86(4):529-34. PubMed ID: 18724221
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool.
Gebauer BS; Hricik DE; Atallah A; Bryan K; Riley J; Tary-Lehmann M; Greenspan NS; Dejelo C; Boehm BO; Hering BJ; Heeger PS
Am J Transplant; 2002 Oct; 2(9):857-66. PubMed ID: 12392292
[TBL] [Abstract][Full Text] [Related]
16. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
[TBL] [Abstract][Full Text] [Related]
17. Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
Waerlop G; Leroux-Roels G; Pagnon A; Begue S; Salaun B; Janssens M; Medaglini D; Pettini E; Montomoli E; Gianchecchi E; Lambe T; Godfrey L; Bull M; Bellamy D; Amdam H; Bredholt G; Cox RJ; Clement F
J Immunol Methods; 2023 Dec; 523():113584. PubMed ID: 37918618
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients.
Augustine JJ; Poggio ED; Clemente M; Aeder MI; Bodziak KA; Schulak JA; Heeger PS; Hricik DE
J Am Soc Nephrol; 2007 May; 18(5):1602-6. PubMed ID: 17389735
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-Linked Immunosorbent Spot (ELISpot) monitoring of cytokine-producing cells for the prediction of acute rejection in renal transplant patients.
Mohammadi F; Solgi G; Tajik M; Ahmadpoor P; Nikoeinejad H; Einollahi B; Nazari B; Lessan-Pezeshki M; Amirzargar A
Eur Cytokine Netw; 2017 Sep; 28(3):93-101. PubMed ID: 29187340
[TBL] [Abstract][Full Text] [Related]
20. Donor-specific ELISPOT assay for predicting acute rejection and allograft function after kidney transplantation: A systematic review and meta-analysis.
Udomkarnjananun S; Kerr SJ; Townamchai N; van Besouw NM; Hesselink DA; Baan CC
Clin Biochem; 2021 Aug; 94():1-11. PubMed ID: 33882287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
